Recurrent mutations in both cohesin and CTCF chromatin remodeling complexes are seen in myeloid malignancies, including AML (~10%-15%), and in more than one half of cases of acute megakaryoblastic leukemia associated with Down Syndrome (DS-AMKL) [14,79]. This evidence concerns the gene CTCF and acute myeloid leukemia.